Form 4: Myomo Inc. Chief Medical Officer Reports Stock Transaction
SEC Form 4 Filing
Harry Kovelman, Chief Medical Officer of Myomo, Inc., reports the disposition of 128 shares of common stock to cover income taxes from a restricted stock unit vesting.
Summary
- On August 5, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., disposed of 128 shares of common stock.
- The transaction was executed to cover income taxes resulting from the vesting of a restricted stock unit grant on August 2, 2024.
- The shares were sold at a price of $3.96 per share.
- Following the transaction, Kovelman directly owns 132,424 shares of Myomo, Inc.
- The sale was made pursuant to an irrevocable election made by Kovelman in conjunction with the original grant in November 2020.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding a stock transaction related to executive compensation, indicating a neutral sentiment.
Industry Context
This is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares sold to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| November 2020 | Original grant of restricted stock units with irrevocable election. |
| 08/02/2024 | Restricted stock unit vesting date. |
| 08/05/2024 | Date of stock sale to cover income taxes. |
| 08/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.